Novis Pharmaceutical Private Limited
Pharmaceutical company that manufactures, imports, exports, and trades various medical and therapeutic products.
2021 | Delhi (India) | Active
Novis Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 21 Days
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -68.78%
- Profit Growth 87.65%
- Ebitda 14154.84%
- Net Worth -1.45%
- Total Assets 82.30%
About Novis Pharmaceutical
Novis Pharmaceutical Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 February 2021 (Four years 21 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ajay Kumar and Virender Kumar serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230DL2021PTC376623
- Company No.
376623
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Feb 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Healthcare
Information Technology
Who are the key members and board of directors at Novis Pharmaceutical?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Kumar  | Managing Director | 06-Feb-2021 | Current |
| Virender Kumar | Managing Director | 06-Feb-2021 | Current |
Board Members
No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.
Financial Performance of Novis Pharmaceutical.
Novis Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 68.78% decrease. The company also saw a substantial improvement in profitability, with a 87.65% increase in profit. The company's net worth dipped by a decrease of 1.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Novis Pharmaceutical?
Unlock access to Novis Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Novis Pharmaceutical?
Novis Pharmaceutical has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novis Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novis Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.